Wed, Feb 4, 2026
Articles In Press
Back to the articles list |
Back to browse issues page
1- Department of Physical Medicine and Rehabilitation, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract: (14 Views)
Purpose: TECAR therapy is a newly emerged physiotherapy technique, demonstrating beneficial effects for different musculoskeletal pains. No earlier studies have investigated the effectiveness of this method for plantar fasciitis (PF) management.
Methods: A double-blind, randomized clinical study was performed involving 60 individuals with PF. The control group underwent a conventional treatment (a set of sport, a silicone heel pad use, and Celecoxib consumption). The intervention group underwent TECAR therapy (twice per week for 4 weeks) in addition to the conservative treatment. The Modified Roles and Maudsley (RM) score, visual analog scale (VAS), and plantar fascia thickness (PFT) were compared between the two groups at baseline, immediately post intervention, and after 2 months following the interventions.
Results: A total of 60 participants (aged 41.68±13.17 years) were enrolled equally in each group. Following treatment, both groups showed significant decrease in VAS and RM scores over time (p<0.001). However, TECAR therapy resulted in significantly greater pain relief at both post-treatment time points (p<0.001). A time-dependent decrease in PFT was evident in both study groups (p < 0.001). There was no significant difference in PFT between groups at baseline, but it was significantly lower in the TECAR group immediately after the intervention and at two months (p=0.015 and p=0.028, respectively). Each group showed a notable enhancement in RM scores over time, yet no statistically significant disparity was found between the groups at any measurement phase.
Discussion: TECAR therapy appears to be an effective adjuvant to conservative treatment for PF, providing greater short- and mid-term pain relief and PFT reduction.
Methods: A double-blind, randomized clinical study was performed involving 60 individuals with PF. The control group underwent a conventional treatment (a set of sport, a silicone heel pad use, and Celecoxib consumption). The intervention group underwent TECAR therapy (twice per week for 4 weeks) in addition to the conservative treatment. The Modified Roles and Maudsley (RM) score, visual analog scale (VAS), and plantar fascia thickness (PFT) were compared between the two groups at baseline, immediately post intervention, and after 2 months following the interventions.
Results: A total of 60 participants (aged 41.68±13.17 years) were enrolled equally in each group. Following treatment, both groups showed significant decrease in VAS and RM scores over time (p<0.001). However, TECAR therapy resulted in significantly greater pain relief at both post-treatment time points (p<0.001). A time-dependent decrease in PFT was evident in both study groups (p < 0.001). There was no significant difference in PFT between groups at baseline, but it was significantly lower in the TECAR group immediately after the intervention and at two months (p=0.015 and p=0.028, respectively). Each group showed a notable enhancement in RM scores over time, yet no statistically significant disparity was found between the groups at any measurement phase.
Discussion: TECAR therapy appears to be an effective adjuvant to conservative treatment for PF, providing greater short- and mid-term pain relief and PFT reduction.
Keywords: Plantar Fasciitis, Physical Therapy Modalities, TECAR therapy, Heel pain, Non-invasive therapy
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
